亚洲一二三区无码蜜桃,99热精品五月,欧美日韩特黄视频,′国产亚洲aV,日韩精品第53页,国产日韩欧美综合在线,日韩欧美国涩,一区二区色欲在线,99热日逼

Nuclear Medicine And Molecular Imaging
收藏雜志
  • 數(shù)據(jù)庫收錄SCIE
  • 年發(fā)文量39

Nuclear Medicine And Molecular Imaging

期刊中文名:核醫(yī)學與分子成像ISSN:1869-3474E-ISSN:1869-3482

該雜志國際簡稱:NUCL MED MOLEC IMAG,是由出版商Springer Nature出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術(shù)發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術(shù)影響力。

基本信息:
期刊簡稱:NUCL MED MOLEC IMAG
是否OA:未開放
是否預警:
Gold OA文章占比:5.93%
出版信息:
出版周期:6 issues per year
出版語言:English
出版商:Springer Nature
評價信息:
JCR分區(qū):Q3
影響因子:1.3
CiteScore:2.2
雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗

雜志介紹

Nuclear Medicine And Molecular Imaging雜志介紹

《Nuclear Medicine And Molecular Imaging》是一本以English為主的未開放獲取國際優(yōu)秀期刊,中文名稱核醫(yī)學與分子成像,本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.3,最新CiteScore 指數(shù)為2.2。

本刊近期中國學者發(fā)表的論文主要有:

  • The Complementary Role of PET to Pathology in Differentiating the Primary Origin of a Malignant Skin Nodule from Liver or Lung

    Author: Ho, Ivan; Chen, Sirong; Yip, Yu; Ho, Chi Lai

  • Diagnosis of Seronegative Rheumatoid Arthritis by (68) Ga-FAPI PET/CT

    Author: Cheung, Shing Kee; Chen, Sirong; Wong, Yuet Hung; Wu, Kwan Kit; Ho, Chi Lai

英文介紹

Nuclear Medicine And Molecular Imaging雜志英文介紹

nuclear Medicine And Molecular Imaging (nucl Med Mol Imaging) Is An Official Journal Of The Korean Society Of Nuclear Medicine, Which Bimonthly Publishes Papers On February, April, June, August, October, And December About Nuclear Medicine And Related Sciences Such As Radiochemistry, Radiopharmacy, Dosimetry And Pharmacokinetics / Pharmacodynamics Of Radiopharmaceuticals, Nuclear And Molecular Imaging Analysis, Nuclear And Molecular Imaging Instrumentation, Radiation Biology And Radionuclide Therapy. The Journal Specially Welcomes Works Of Artificial Intelligence Applied To Nuclear Medicine. The Journal Will Also Welcome Original Works Relating To Molecular Imaging Research Such As The Development Of Molecular Imaging Probes, Reporter Imaging Assays, Imaging Cell Trafficking, Imaging Endo(exo)genous Gene Expression, And Imaging Signal Transduction. Nucl Med Mol Imaging Publishes The Following Types Of Papers: Original Articles, Reviews, Case Reports, Editorials, Interesting Images, And Letters To The Editor.

the Korean Society Of Nuclear Medicine (ksnm) ksnm Is A Scientific And Professional Organization Founded In 1961 And A Member Of The Korean Academy Of Medical Sciences Of The Korean Medical Association Which Was Established By The Medical Services Law. The Aims Of Ksnm Are The Promotion Of Nuclear Medicine And Cooperation Of Each Member. The Business Of Ksnm Includes Holding Academic Meetings And Symposia, The Publication Of Journals And Books, Planning And Research Of Promoting Science And Health, And Training And Qualification Of Nuclear Medicine Specialists.

JCR分區(qū)(2023-2024年最新版)

Nuclear Medicine And Molecular Imaging雜志 JCR分區(qū)信息

按JIF指標學科分區(qū)
學科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q3
排名:138 / 204
百分位:

32.6%

按JCI指標學科分區(qū)
學科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
收錄子集:ESCI
分區(qū):Q3
排名:152 / 204
百分位:

25.74%

JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學科。JCR分區(qū)根據(jù)每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

CiteScore 評價數(shù)據(jù)(2024年最新版)

Nuclear Medicine And Molecular Imaging雜志CiteScore 評價數(shù)據(jù)

  • CiteScore 值:2.2
  • SJR:0.34
  • SNIP:0.423
學科類別 分區(qū) 排名 百分位
大類:Medicine 小類:Radiology, Nuclear Medicine and Imaging Q3 204 / 333

38%

歷年影響因子和期刊自引率

投稿經(jīng)驗

Nuclear Medicine And Molecular Imaging雜志投稿經(jīng)驗

該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認可很高,對稿件內(nèi)容的創(chuàng)新性和學術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

免責聲明

若用戶需要出版服務,請聯(lián)系出版商。

开阳县| 云南省| 云林县| 华蓥市| 永嘉县| 龙陵县| 桦甸市| 布拖县| 白山市| 富顺县| 任丘市| 确山县| 灵武市| 安达市| 永川市| 特克斯县| 资阳市| 三江| 丹阳市| 绥宁县| 黔西县| 木里| 舒兰市| 蒙阴县| 察雅县| 大连市| 茶陵县| 三穗县| 财经| 忻州市| 清流县| 乐平市| 隆回县| 湖南省| 宜宾县| 小金县| 资阳市| 隆昌县| 宁南县| 仁化县| 获嘉县|